Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

News

World Stem Cell Summit panel cautions over stepped up HCT/P enforcement, reimbursement issues

Speaking at the World Stem Cell Summit hosted by the Regenerative Medicine Foundation last week, Hogan Lovells partners Mike Druckman, Stuart Langbein, and Thomas Beimers discussed evolving ...

News

Panelists discuss present & future reimbursement mechanisms for AI health care products

At our recent Health Care AI Law and Policy Summit, Hogan Lovells partner Stuart Langbein moderated a panel discussion on AI policy and reimbursement issues. Joined by representatives from...

News

FDA outlines rescission of Breakthrough Therapy Designation

Last week, the U.S. Food and Drug Administration (FDA) issued the draft guidance “Considerations for Rescinding Breakthrough Therapy Designation,” which outlines how FDA will...

News

Let’s talk about “Return Chains”

The new requirements under the German Packaging Act (Verpackungsgesetz, VerpackG) present a challenge and an opportunity for companies that have to re-design their operational processes to...

News

FTC workshop highlights potential changes to agency’s review of pharmaceutical mergers

On June 14 and 15, 2022 the Federal Trade Commission (FTC) hosted a workshop titled “Future of Pharmaceuticals: Examining the Analysis of Pharmaceutical Mergers.” The...

Insights

China's recent updates in the life science industry: strengthening emphasis on quality management
Registered Content

Recently, the PRC National Medical Product Administration has released several pieces of regulations or drafting rules with respect to the administration and supervision of drugs and...

News

FDA invites comments on xenotransplantation product regulatory standards ahead of public meeting

On June 29-30, 2022, the U.S. Food and Drug Administration (FDA) will hold a virtual public meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) to discuss its...

News

Private equity In health care: In the antitrust crosshairs

Transactions and other investments in the health care industry by private equity firms are a hot enforcement topic at both the U.S. Federal Trade Commission (“FTC”) and the...

Insights

UK Real Estate Life Sciences: what are the issues facing landlords, developers and investors?
Registered Content

Over the last eighteen months we have seen more and more landlords, developers and investors looking at opportunities to invest in the UK life sciences sector. As with any new and...

Loading data